285 related articles for article (PubMed ID: 12499282)
1. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
Levitt RJ; Pollak M
Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
Jendrossek V; Handrick R; Belka C
FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
[TBL] [Abstract][Full Text] [Related]
6. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
8. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
[TBL] [Abstract][Full Text] [Related]
13. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
14. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
Clin Cancer Res; 2004 Sep; 10(17):5930-9. PubMed ID: 15355926
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
Swamy MV; Herzog CR; Rao CV
Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
18. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
Williams CS; Watson AJ; Sheng H; Helou R; Shao J; DuBois RN
Cancer Res; 2000 Nov; 60(21):6045-51. PubMed ID: 11085526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
